Prostate cancer is the most frequent malignancy in the worldwide male population; it is also
one of the most common among all the leading cancer-related death causes. In the last two …

Simple Summary Despite recent therapeutic advances in the treatment of prostate cancer,
metastatic castration-resistant prostate cancer continues to cause significant morbidity and …

Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is a cell surface antigen for
therapeutic targeting in prostate cancer. Here, we report broad expression of STEAP1 …

The tumor-associated antigen STEAP1 is a potential therapeutic target that is expressed in
most prostate tumors and at increased levels in metastatic castration-resistant prostate …

Objective. To investigate the expression patterns and prognostic values of STEAP family
members in the occurrence and development of breast cancer. Materials and Methods. The …

The human six-transmembrane epithelial antigen of the prostate (STEAP) proteins, which
include STEAP1–4 and atypical STEAP1B, contain six transmembrane domains and are …

Purpose. This study is aimed at systematically analyzing the expression, function, and
prognostic value of six transmembrane epithelial antigen of the prostate 1 (STEAP1) in …

STEAP1 is a cell surface protein of the STEAP family whose main function focuses on
intercellular communication and cell growth. STEAP1 is considered a promising putative …

Background Upregulation of the six-transmembrane epithelial antigen of prostate-1
(STEAP1) is closely associated with prognosis of numerous malignant cancers. However, its …

Prostate cancer is a multifactorial disease and the second most common cancer diagnosed
in men worldwide. The six transmembrane epithelial antigen of prostate (STEAP) proteins …